Also listed under Breast Diseases
ClinicalTrials.gov term: Breast Neoplasms
323 trials changed in the last 30 days: 9 stopped, 155 with notable changes, 159 with minor changes only.
Trial terminated
Also in this update: Primary completion date changed from estimate of Sep 2026 to Jul 29, 2026; Final enrollment: 20 participants (planned 90)
Processa PharmaceuticalsPhase 2 NCT06568692 Registry history of NCT06568692 on ClinicalTrials.gov (opens the registry)
Trial terminated
Also in this update: Primary completion date changed from estimate of Jun 2026 to Dec 23, 2025
Spanish Breast Cancer Research GroupPhase 3 NCT05063786 Registry history of NCT05063786 on ClinicalTrials.gov (opens the registry)
Trial terminated
Also in this update: Primary completion date changed from estimate of Apr 2025 to Sep 11, 2026
Dr Rajendra A. BadwePhase 3 NCT01785420 Registry history of NCT01785420 on ClinicalTrials.gov (opens the registry)
Trial terminated
Also in this update: Final enrollment: 4 participants — 2% of the 162 planned; Primary completion date changed from estimate of Jul 2028 to Mar 30, 2025
UNICANCERPhase 2 NCT05625087 Registry history of NCT05625087 on ClinicalTrials.gov (opens the registry)
Trial terminated
Also in this update: Final enrollment: 3 participants — 3% of the 120 planned; Primary completion date changed from estimate of Sep 1, 2027 to Jan 30, 2026
SystImmune Inc.Phase 1 NCT06714617 Registry history of NCT06714617 on ClinicalTrials.gov (opens the registry)
Trial terminated
Also in this update: Study completion date changed from estimate of Aug 18, 2026 to Aug 18, 2025; Final enrollment: 7 participants (planned 40)
GenieBiome LimitedNot applicable NCT06560385 Registry history of NCT06560385 on ClinicalTrials.gov (opens the registry)
Trial status changed: Recruiting → Withdrawn
Also in this update: Start date changed from estimate of Oct 31, 2026 to Jun 10, 2025; Primary completion date changed from estimate of Aug 30, 2027 to Sep 22, 2026
Centre Oscar LambretPhase 2 NCT06807164 Registry history of NCT06807164 on ClinicalTrials.gov (opens the registry)
Recruitment suspended
M.D. Anderson Cancer CenterPhase 1 NCT06959537 Registry history of NCT06959537 on ClinicalTrials.gov (opens the registry)
Trial terminated
Also in this update: Final enrollment: 31 participants — 7% of the 472 planned; Primary completion date changed from estimate of Sep 1, 2026 to Dec 1, 2025
UNICANCERNot applicable NCT06505018 Registry history of NCT06505018 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Oct 28, 2028 to Oct 28, 2029
Also in this update: Recruitment opened; Trial sites expanded: 0 → 6 locations
Antares Therapeutics, IncPhase 1/2 NCT07767474 Registry history of NCT07767474 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Jul 30, 2026 to Jul 30, 2027
MediLink Therapeutics (Suzhou) Co., Ltd.Phase 2 NCT06439771 Registry history of NCT06439771 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Dec 31, 2025 to Dec 31, 2027
Also in this update: Study completion pushed from Dec 30, 2026 to Dec 31, 2027
Shandong Boan Biotechnology Co., LtdPhase 1 NCT06596915 Registry history of NCT06596915 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Nov 20, 2025 to Nov 20, 2027
Also in this update: Recruitment opened
Henan Cancer HospitalPhase 2 NCT06663748 Registry history of NCT06663748 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Sep 30, 2026 to Jun 30, 2028
Novartis PharmaceuticalsNot specified NCT07710716 Registry history of NCT07710716 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Jun 1, 2026 to Jun 1, 2028
Also in this update: Trial status changed: Unknown → Recruiting; Study completion pushed from Aug 1, 2026 to Aug 1, 2028
Henan Cancer HospitalPhase 2 NCT06598046 Registry history of NCT06598046 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Dec 2026 to Aug 2027
Shandong Suncadia Medicine Co., Ltd.Phase 3 NCT07024173 Registry history of NCT07024173 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Apr 30, 2026 to Nov 30, 2026
Tolmar Inc.Phase 3 NCT04906395 Registry history of NCT04906395 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Aug 15, 2027 to May 15, 2029
Also in this update: Study completion pushed from Sep 15, 2027 to Jun 15, 2029
Mayo ClinicPhase 2 NCT06028022 Registry history of NCT06028022 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Feb 28, 2027 to Jan 28, 2029
Mayo ClinicPhase 2 NCT06855524 Registry history of NCT06855524 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Mar 1, 2029 to Sep 22, 2029
Also in this update: Study completion pushed from Mar 1, 2030 to May 29, 2034
Medical University of South CarolinaPhase 2 NCT07743190 Registry history of NCT07743190 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Study completion date changed from estimate of Dec 2026 to Sep 9, 2026
Eli Lilly and CompanyPhase 2 NCT02747004 Registry history of NCT02747004 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Primary completion date changed from estimate of Dec 2026 to Apr 2, 2025
Eli Lilly and CompanyPhase 1 NCT05307705 Registry history of NCT05307705 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Study completion date changed from estimate of Jul 30, 2026 to Aug 31, 2026
Daiichi SankyoPhase 3 NCT03529110 Registry history of NCT03529110 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Jul 31, 2026 to Dec 31, 2026
BicycleTx LimitedPhase 1/2 NCT04180371 Registry history of NCT04180371 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Study completion date changed from estimate of Aug 1, 2026 to May 19, 2026
Daiichi SankyoPhase 3 NCT03734029 Registry history of NCT03734029 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Dec 2026 to Oct 14, 2026
Memorial Sloan Kettering Cancer CenterPhase 1/2 NCT03377387 Registry history of NCT03377387 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Abramson Cancer Center at Penn MedicinePhase 2 NCT04841148 Registry history of NCT04841148 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Jun 30, 2026 to Nov 30, 2026
Also in this update: Enrollment increased: 115 → 160 participants; Study completion pushed from Dec 30, 2026 to Dec 30, 2028
Medicenna Therapeutics, Inc.Phase 1/2 NCT05086692 Registry history of NCT05086692 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Dec 31, 2026 to Sep 10, 2026
PfizerPhase 1/2 NCT06125522 Registry history of NCT06125522 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Primary completion pushed from Oct 2026 to Feb 2027; Study completion moved earlier from Oct 2030 to Feb 2030
University of Michigan Rogel Cancer CenterPhase 1 NCT05996107 Registry history of NCT05996107 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Study completion pushed from Aug 15, 2026 to Aug 6, 2027; Primary completion date changed from estimate of Jun 15, 2026 to Aug 7, 2026
Avacta Life Sciences LtdPhase 1 NCT04969835 Registry history of NCT04969835 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Jun 30, 2026 to Apr 9, 2026
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.Phase 1 NCT05311397 Registry history of NCT05311397 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Study completion pushed from Dec 2026 to Sep 2028
ExpreS2ion BiotechnologiesPhase 1 NCT06746688 Registry history of NCT06746688 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Study completion date changed from estimate of Sep 30, 2026 to Jun 30, 2026; Final enrollment: 506 participants (planned 1116)
Medstar Health Research InstituteNot applicable NCT05301114 Registry history of NCT05301114 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Study completion date changed from estimate of Dec 15, 2026 to May 30, 2023
Alliance for Clinical Trials in OncologyNot applicable NCT03766009 Registry history of NCT03766009 on ClinicalTrials.gov (opens the registry)
Trial completed
Gazi UniversityNot applicable NCT07798492 Registry history of NCT07798492 on ClinicalTrials.gov (opens the registry)
Completed without a posted recruiting period
Also in this update: Primary completion date changed from estimate of Nov 30, 2028 to Apr 6, 2026
Dana-Farber Cancer InstituteNot applicable NCT07519200 Registry history of NCT07519200 on ClinicalTrials.gov (opens the registry)
Trial completed
Pharmanutra S.p.a.Not applicable NCT06137833 Registry history of NCT06137833 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Study completion pushed from Sep 30, 2026 to Dec 30, 2026
The Fourth Affiliated Hospital of China Medical UniversityNot applicable NCT07339306 Registry history of NCT07339306 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Xijing HospitalNot applicable NCT07071402 Registry history of NCT07071402 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Mount Carmel Health SystemNot specified NCT03536897 Registry history of NCT03536897 on ClinicalTrials.gov (opens the registry)
Completed without a posted recruiting period
Also in this update: Primary completion date changed from estimate of Mar 31, 2027 to Jul 7, 2026
Lahore University of Biological and Applied SciencesNot applicable NCT07217288 Registry history of NCT07217288 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Final enrollment: 26 participants (planned 75)
University of PennsylvaniaNot specified NCT01996046 Registry history of NCT01996046 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Study completion pushed from May 31, 2026 to Dec 31, 2026
The Fourth Affiliated Hospital of China Medical UniversityNot specified NCT06994416 Registry history of NCT06994416 on ClinicalTrials.gov (opens the registry)
Enrollment increased: 285 → 330 participants
ModeX Therapeutics, An OPKO Health CompanyPhase 1/2 NCT06239194 Registry history of NCT06239194 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Dec 31, 2027 to Jul 18, 2025; Final enrollment: 20 participants (planned 24)
Barbara Ann Karmanos Cancer InstitutePhase 1 NCT05556473 Registry history of NCT05556473 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Dec 31, 2027 to Jun 15, 2028
And 2 more changes in the last 30 days
Hoffmann-La RochePhase 3 NCT05296798 Registry history of NCT05296798 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Jul 2031 to Oct 2031
University of Kansas Medical CenterPhase 2 NCT07643584 Registry history of NCT07643584 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from May 31, 2028 to Oct 31, 2028
Hoffmann-La RocheNot specified NCT07527741 Registry history of NCT07527741 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Oregon State UniversityPhase 1 NCT07055854 Registry history of NCT07055854 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Study completion pushed from Nov 1, 2026 to May 1, 2027
University Health Network, TorontoPhase 3 NCT04874038 Registry history of NCT04874038 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Fudan UniversityPhase 3 NCT06447623 Registry history of NCT06447623 on ClinicalTrials.gov (opens the registry)
Completed without a posted recruiting period
Also in this update: Primary completion date changed from estimate of Aug 2025 to Oct 22, 2025
Future University in EgyptPhase 3 NCT06774885 Registry history of NCT06774885 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of May 15, 2026 to Sep 15, 2026
Antalya Training and Research HospitalNot specified NCT07338721 Registry history of NCT07338721 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Aug 2038 to Oct 2038
Ataraxis AI, Inc.Not specified NCT07706842 Registry history of NCT07706842 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of May 2026 to Mar 15, 2026
Tanta UniversityPhase 2 NCT07137793 Registry history of NCT07137793 on ClinicalTrials.gov (opens the registry)
Trial completed
University of Wisconsin, MadisonPhase 2 NCT04573231 Registry history of NCT04573231 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Memorial Sloan Kettering Cancer CenterPhase 1/2 NCT06110793 Registry history of NCT06110793 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
MedSIRPhase 2 NCT05708235 Registry history of NCT05708235 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Jul 2039 to Oct 2039
Also in this update: Start date pushed from Sep 2026 to Oct 2026
Weill Medical College of Cornell UniversityNot applicable NCT07764744 Registry history of NCT07764744 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Feb 27, 2025 to Jan 5, 2024
Seoul National University HospitalNot specified NCT06255808 Registry history of NCT06255808 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Feb 1, 2027 to Jun 30, 2026
Medical College of WisconsinNot applicable NCT03824145 Registry history of NCT03824145 on ClinicalTrials.gov (opens the registry)
Completed without a posted recruiting period
Tanta UniversityNot applicable NCT07349459 Registry history of NCT07349459 on ClinicalTrials.gov (opens the registry)
Trial status changed: Enrolling by Invitation → Active, Not Recruiting
Also in this update: Primary and study completion pushed from Jul 2026 to Nov 2026
Abramson Cancer Center at Penn MedicineNot specified NCT06332131 Registry history of NCT06332131 on ClinicalTrials.gov (opens the registry)
Trial completed
University of AlicanteNot applicable NCT07275957 Registry history of NCT07275957 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Dec 2027 to Feb 2028
Breathe BioMedical IncNot specified NCT06512350 Registry history of NCT06512350 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 189 → 206 locations
And 1 more change in the last 30 days
BeOne MedicinesPhase 3 NCT07492641 Registry history of NCT07492641 on ClinicalTrials.gov (opens the registry)
Trial sites reduced: 463 → 460 locations
PfizerPhase 3 NCT06760637 Registry history of NCT06760637 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Sep 2026 to Dec 2026
University of OklahomaNot applicable NCT07238023 Registry history of NCT07238023 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Study completion date changed from estimate of Dec 31, 2026 to Aug 10, 2025
Dana-Farber Cancer InstituteNot specified NCT03749421 Registry history of NCT03749421 on ClinicalTrials.gov (opens the registry)
Trial completed
UNC Lineberger Comprehensive Cancer CenterNot applicable NCT07396766 Registry history of NCT07396766 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Dec 2026 to May 20, 2026; Final enrollment: 37 participants (planned 158)
University of FloridaNot applicable NCT05913713 Registry history of NCT05913713 on ClinicalTrials.gov (opens the registry)
Trial completed
Montefiore Medical CenterNot specified NCT03697577 Registry history of NCT03697577 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Final enrollment: 70 participants (planned 52)
ATİYE KAŞ ÖZDEMİRNot specified NCT06966791 Registry history of NCT06966791 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Oct 2026 to Mar 10, 2022; Final enrollment: 120 participants (planned 180)
Institut BergoniéNot applicable NCT03357120 Registry history of NCT03357120 on ClinicalTrials.gov (opens the registry)
Trial completed
Centre Oscar LambretNot specified NCT02281149 Registry history of NCT02281149 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 372 → 376 locations
Gilead SciencesPhase 3 NCT05633654 Registry history of NCT05633654 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 325 → 331 locations
Merck Sharp & Dohme LLCPhase 3 NCT06966700 Registry history of NCT06966700 on ClinicalTrials.gov (opens the registry)
Trial sites reduced: 167 → 157 locations
PfizerPhase 1/2 NCT06966453 Registry history of NCT06966453 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 11 → 19 locations
Stemline Therapeutics, Inc.Phase 2 NCT07766018 Registry history of NCT07766018 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Aug 31, 2026 to Oct 31, 2026
Alliance for Clinical Trials in OncologyPhase 3 NCT04379570 Registry history of NCT04379570 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 23 → 26 locations
TerSera Therapeutics LLCPhase 1 NCT07310420 Registry history of NCT07310420 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 203 → 239 locations
Celcuity IncPhase 3 NCT06757634 Registry history of NCT06757634 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 203 → 206 locations
And 3 more changes in the last 30 days
National Cancer Institute (NCI)Phase 3 NCT07391774 Registry history of NCT07391774 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Sep 26, 2028 to Dec 21, 2028
Also in this update: Study completion moved earlier from Sep 26, 2029 to Jun 21, 2029
Mayo ClinicPhase 2 NCT07460752 Registry history of NCT07460752 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Dec 18, 2026 to May 15, 2027
Mayo ClinicPhase 2 NCT07285044 Registry history of NCT07285044 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Sep 30, 2026 to Dec 30, 2026
Also in this update: Study completion pushed from Dec 30, 2026 to Mar 30, 2027
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 2 NCT03573648 Registry history of NCT03573648 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Aug 31, 2030 to Oct 31, 2030
Also in this update: Study completion pushed from Aug 31, 2031 to Oct 31, 2031
Washington University School of MedicinePhase 2 NCT07619365 Registry history of NCT07619365 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 186 → 206 locations
Hoffmann-La RochePhase 2/3 NCT07413939 Registry history of NCT07413939 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 202 → 212 locations
And 1 more change in the last 30 days
BioNTech SEPhase 3 NCT07173751 Registry history of NCT07173751 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 311 → 314 locations
Merck Sharp & Dohme LLCPhase 3 NCT06393374 Registry history of NCT06393374 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 231 → 243 locations
Relay Therapeutics, Inc.Phase 3 NCT06982521 Registry history of NCT06982521 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Aug 25, 2026 to Dec 25, 2026
Roswell Park Cancer InstituteNot applicable NCT03897270 Registry history of NCT03897270 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Apr 30, 2027 to Sep 20, 2027
Also in this update: Study completion pushed from Feb 17, 2028 to Sep 2028
Institut de Cancérologie de LorraineNot applicable NCT06552091 Registry history of NCT06552091 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Sep 2026 to Mar 2027
Also in this update: Study completion pushed from Aug 2027 to Jun 2028
Fundacion Miguel ServetNot applicable NCT07531836 Registry history of NCT07531836 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Aug 31, 2026 to Oct 31, 2026
Also in this update: Study completion pushed from Sep 15, 2026 to Dec 2028
Dana-Farber Cancer InstituteNot applicable NCT04720209 Registry history of NCT04720209 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Jun 2032 to Nov 1, 2032
Peter MacCallum Cancer Centre, AustraliaNot applicable NCT06882499 Registry history of NCT06882499 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Nov 15, 2026 to Jan 20, 2027
Also in this update: Study completion pushed from Dec 15, 2026 to Jan 20, 2027
Dartmouth-Hitchcock Medical CenterNot applicable NCT06522568 Registry history of NCT06522568 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Jun 2026 to Oct 2026
Also in this update: Study completion pushed from Jun 2026 to Nov 2027
Centre Oscar LambretNot applicable NCT04653740 Registry history of NCT04653740 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 64 → 74 locations
Genentech, Inc.Phase 1/2 NCT07100106 Registry history of NCT07100106 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 181 → 200 locations
Olema Pharmaceuticals, Inc.Phase 3 NCT07085767 Registry history of NCT07085767 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 8 → 25 locations
Olema Pharmaceuticals, Inc.Phase 1 NCT06784193 Registry history of NCT06784193 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 3 → 7 locations
Avacta Life Sciences LtdPhase 1 NCT07454642 Registry history of NCT07454642 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 91 → 94 locations
Daiichi SankyoPhase 2 NCT06172478 Registry history of NCT06172478 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 35 → 44 locations
Jazz PharmaceuticalsPhase 2 NCT07102381 Registry history of NCT07102381 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 54 → 60 locations
ALX Oncology Inc.Phase 2 NCT07007559 Registry history of NCT07007559 on ClinicalTrials.gov (opens the registry)
Primary and study completion moved earlier from Dec 31, 2027 to Nov 30, 2027
AstraZenecaPhase 3 NCT06764186 Registry history of NCT06764186 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 12 → 22 locations
Pliant Therapeutics, Inc.Phase 1 NCT06270706 Registry history of NCT06270706 on ClinicalTrials.gov (opens the registry)
Trial sites reduced: 23 → 20 locations
AstraZenecaPhase 1 NCT05877599 Registry history of NCT05877599 on ClinicalTrials.gov (opens the registry)
Enrollment increased: 118 → 173 participants
University of Southern CaliforniaNot specified NCT07259304 Registry history of NCT07259304 on ClinicalTrials.gov (opens the registry)
Enrollment increased: 172 → 210 participants
Mälardalen UniversityNot applicable NCT06719206 Registry history of NCT06719206 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 83 → 88 locations
And 1 more change in the last 30 days
American Society of Clinical OncologyPhase 3 NCT06377852 Registry history of NCT06377852 on ClinicalTrials.gov (opens the registry)
Study completion pushed from Sep 4, 2026 to Jan 15, 2027
Daiichi SankyoNot specified NCT07092254 Registry history of NCT07092254 on ClinicalTrials.gov (opens the registry)
Study completion pushed from Dec 31, 2026 to Nov 30, 2027
Also in this update: Primary completion date changed from estimate of Dec 31, 2026 to Nov 30, 2025
Klus Pharma Inc.Phase 1/2 NCT04152499 Registry history of NCT04152499 on ClinicalTrials.gov (opens the registry)
Study completion pushed from Oct 30, 2026 to Dec 30, 2026
Also in this update: Primary completion date changed from estimate of Jun 12, 2026 to Feb 10, 2026
Sichuan Huiyu Pharmaceutical Co., LtdNot applicable NCT06765590 Registry history of NCT06765590 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 690 → 702 locations
Alliance for Clinical Trials in OncologyPhase 3 NCT06876714 Registry history of NCT06876714 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 467 → 486 locations
Wake Forest University Health SciencesNot specified NCT06418204 Registry history of NCT06418204 on ClinicalTrials.gov (opens the registry)
Primary completion date changed from estimate of Aug 24, 2026 to Jun 26, 2026
AstraZenecaPhase 3 NCT04711252 Registry history of NCT04711252 on ClinicalTrials.gov (opens the registry)
Interventions modified
Merck Sharp & Dohme LLCPhase 3 NCT07060807 Registry history of NCT07060807 on ClinicalTrials.gov (opens the registry)
Primary completion date changed from estimate of Jun 2026 to Aug 12, 2026
DualityBio Inc.Phase 3 NCT06018337 Registry history of NCT06018337 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 18 → 23 locations
Alliance for Clinical Trials in OncologyNot applicable NCT07059884 Registry history of NCT07059884 on ClinicalTrials.gov (opens the registry)
Study completion pushed from Sep 30, 2026 to Mar 31, 2027
Astellas Pharma Global Development, Inc.Phase 2 NCT04225117 Registry history of NCT04225117 on ClinicalTrials.gov (opens the registry)
Trial arms changed: 4 → 5
Cellectar Biosciences, Inc.Phase 1 NCT07311993 Registry history of NCT07311993 on ClinicalTrials.gov (opens the registry)
Start date changed from estimate of Sep 22, 2026 to Sep 8, 2026
Novartis PharmaceuticalsPhase 1 NCT07801508 Registry history of NCT07801508 on ClinicalTrials.gov (opens the registry)
Interventions modified
Janssen Research & Development, LLCPhase 1 NCT07524855 Registry history of NCT07524855 on ClinicalTrials.gov (opens the registry)
Start date moved earlier from Jul 14, 2026 to Jun 22, 2026
Mucahide Emine Fidancı KuasNot applicable NCT07843212 Registry history of NCT07843212 on ClinicalTrials.gov (opens the registry)
Study completion moved earlier from Aug 31, 2027 to Apr 5, 2027
ECOG-ACRIN Cancer Research GroupPhase 2 NCT04001829 Registry history of NCT04001829 on ClinicalTrials.gov (opens the registry)
Study completion pushed from Aug 29, 2026 to Feb 15, 2027
Also in this update: Primary completion date changed from estimate of Aug 29, 2026 to Oct 6, 2026
Ankara Etlik City HospitalNot specified NCT07162675 Registry history of NCT07162675 on ClinicalTrials.gov (opens the registry)
Primary completion date changed from estimate of Sep 2026 to Jun 22, 2026
University of NebraskaPhase 2 NCT05069038 Registry history of NCT05069038 on ClinicalTrials.gov (opens the registry)
Interventions modified
Memorial Sloan Kettering Cancer CenterNot applicable NCT06127979 Registry history of NCT06127979 on ClinicalTrials.gov (opens the registry)
Study completion pushed from Sep 11, 2026 to Sep 30, 2027
National Cancer Institute (NCI)Phase 2 NCT02883062 Registry history of NCT02883062 on ClinicalTrials.gov (opens the registry)
Primary completion date changed from estimate of May 30, 2025 to Nov 30, 2024
Jules Bordet InstitutePhase 2 NCT03875573 Registry history of NCT03875573 on ClinicalTrials.gov (opens the registry)
Study completion pushed from Dec 2025 to Dec 2028
Also in this update: Primary completion date changed from estimate of Mar 2025 to May 21, 2021
Jules Bordet InstitutePhase 1/2 NCT03616886 Registry history of NCT03616886 on ClinicalTrials.gov (opens the registry)
Study completion pushed from Sep 1, 2026 to Feb 1, 2027
SWOG Cancer Research NetworkNot specified NCT03939481 Registry history of NCT03939481 on ClinicalTrials.gov (opens the registry)
Study completion pushed from Sep 18, 2026 to Sep 8, 2027
City of Hope Medical CenterNot specified NCT01472094 Registry history of NCT01472094 on ClinicalTrials.gov (opens the registry)
Study completion pushed from Aug 24, 2026 to Nov 7, 2027
Washington University School of MedicinePhase 2 NCT01723774 Registry history of NCT01723774 on ClinicalTrials.gov (opens the registry)
Study completion pushed from Aug 11, 2026 to Jul 16, 2027
City of Hope Medical CenterPhase 2 NCT00295893 Registry history of NCT00295893 on ClinicalTrials.gov (opens the registry)
Study completion pushed from Aug 11, 2026 to Jul 14, 2027
City of Hope Medical CenterNot applicable NCT02293954 Registry history of NCT02293954 on ClinicalTrials.gov (opens the registry)
Study completion pushed from Aug 31, 2026 to Apr 25, 2027
NYU Langone HealthNot specified NCT03927768 Registry history of NCT03927768 on ClinicalTrials.gov (opens the registry)
Trial arms changed: 3 → 2
Centre Francois BaclesseNot applicable NCT05414357 Registry history of NCT05414357 on ClinicalTrials.gov (opens the registry)
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Qilu Pharmaceutical Co., Ltd.Phase 4 NCT06616571 Registry history of NCT06616571 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting
Suzhou Suncadia Biopharmaceuticals Co., Ltd.Phase 2 NCT06592625 Registry history of NCT06592625 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Active, Not Recruiting
Sihuan Pharmaceutical Holdings Group Ltd.Phase 1/2 NCT04539496 Registry history of NCT04539496 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Aug 2023); last known: Recruiting
Chongqing Precision Biotech Co., LtdPhase 1 NCT06010862 Registry history of NCT06010862 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Light Chain Bioscience - Novimmune SAPhase 1 NCT05403554 Registry history of NCT05403554 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Henan Cancer HospitalPhase 3 NCT04547907 Registry history of NCT04547907 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Fujian Cancer HospitalPhase 1/2 NCT05019690 Registry history of NCT05019690 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Active, Not Recruiting
European Institute of OncologyPhase 2 NCT06727357 Registry history of NCT06727357 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting
Wang JiayuPhase 2 NCT06653972 Registry history of NCT06653972 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2022); last known: Recruiting
National Taiwan University HospitalPhase 2 NCT05766410 Registry history of NCT05766410 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Jul 2020); last known: Recruiting
Jiangxi Provincial Cancer HospitalPhase 1/2 NCT04481763 Registry history of NCT04481763 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Oct 2023); last known: Active, Not Recruiting
Sun Yat-sen UniversityPhase 2 NCT04172259 Registry history of NCT04172259 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
First Affiliated Hospital of Zhejiang UniversityPhase 1 NCT04778839 Registry history of NCT04778839 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
University of Rome Tor VergataNot applicable NCT06624917 Registry history of NCT06624917 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Erasmus Medical CenterNot applicable NCT06622954 Registry history of NCT06622954 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Active, Not Recruiting
JeeYeon LeeNot applicable NCT06622967 Registry history of NCT06622967 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Active, Not Recruiting
Universidad de BurgosNot applicable NCT06618690 Registry history of NCT06618690 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Ospedale Policlinico San MartinoNot specified NCT06606535 Registry history of NCT06606535 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting
Liu ShuNot applicable NCT06605690 Registry history of NCT06605690 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting
University of HullNot applicable NCT06595316 Registry history of NCT06595316 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Ren,YuNot specified NCT06593132 Registry history of NCT06593132 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting
Marina Hanna Thabet GhobrialNot specified NCT06592560 Registry history of NCT06592560 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Fudan UniversityNot specified NCT06591039 Registry history of NCT06591039 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting
Seoul National University HospitalNot specified NCT06575049 Registry history of NCT06575049 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Aug 2024); last known: Recruiting
National University of MalaysiaNot applicable NCT06566937 Registry history of NCT06566937 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Peking Union Medical College HospitalNot specified NCT06489158 Registry history of NCT06489158 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Apr 2024); last known: Not Yet Recruiting
Assistance Publique - Hôpitaux de ParisNot specified NCT06418139 Registry history of NCT06418139 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Regina Elena Cancer InstituteNot specified NCT06272799 Registry history of NCT06272799 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Jules Bordet InstituteNot applicable NCT06227338 Registry history of NCT06227338 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Nov 2023); last known: Not Yet Recruiting
DR. DIANE CHISESI NFS. MD. PHD.Not specified NCT06154590 Registry history of NCT06154590 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Active, Not Recruiting
Fondazione Policlinico Universitario Agostino Gemelli IRCCSNot applicable NCT06026631 Registry history of NCT06026631 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since May 2023); last known: Recruiting
Tianjin Medical University Cancer Institute and HospitalNot applicable NCT05890287 Registry history of NCT05890287 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Fondazione Policlinico Universitario Agostino Gemelli IRCCSNot specified NCT05878964 Registry history of NCT05878964 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Guangdong Provincial People's HospitalNot applicable NCT05841186 Registry history of NCT05841186 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Hospital St. Joseph, Marseille, FranceNot applicable NCT05027321 Registry history of NCT05027321 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Aug 2021); last known: Recruiting
University of CopenhagenNot applicable NCT05010356 Registry history of NCT05010356 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
IRCCS San RaffaeleNot applicable NCT04767659 Registry history of NCT04767659 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Georgetown UniversityNot applicable NCT04258280 Registry history of NCT04258280 on ClinicalTrials.gov (opens the registry)
Changed
Registry verification sweep
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Second Affiliated Hospital, Zhejiang University, School of MedicineNot specified NCT06595966 Registry history of NCT06595966 on ClinicalTrials.gov (opens the registry)
Changed
| First posted | Trial | Sponsor | Phase |
|---|---|---|---|
| 2026-10-16 | NCT07878598 Efficacy of Complete Decongestive Therapy for Limb Lymphedema: Response Profile and… | Ryazan State Medical University new | |
| 2026-10-16 | NCT07877740 Feasibility of a Standardized Fascial Plane Block Protocol for Breast Cancer Surgery | Hôpital Fribourgeois new | |
| 2026-10-16 | NCT07877376 Impact of Cognitive Impairment on Chronic Pain in Breast Cancer | Nadine ATTAL new | |
| 2026-10-15 | NCT07874880 MTX-531-001 Phase 1 Study in Advanced Solid Tumors | MEKanistic Therapeutics, Inc. new | Phase 1 |
| 2026-10-08 | NCT07864909 Physical Activity Education and Quality of Life Study in Breast Cancer Chemotherapy… | International Hellenic University new | |
| 2026-10-08 | NCT07865884 Tissue Validation of Mammographic Breast Arterial Calcification in Mastectomy Specimens | Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital new | |
| 2026-10-08 | NCT07865507 Divergent Long-Term Clinical Courses in Two Men With Breast Cancer | Azerbaijan Medical University new | |
| 2026-10-06 | NCT07861932 A Phase 1/2a Study of K-1728 in Advanced Solid Tumors | KymaThera, Inc. new | Phase 1/2 |
| 2026-10-02 | NCT07856225 Clinical and Therapeutic Outcomes by Molecular Subtype in Breast Cancer | Fundación Santa Fe de Bogota new | |
| 2026-09-30 | NCT07850869 A Real-World Observational Study of Intratumoral H101 Oncolytic Adenovirus Combined With… | Jie Yuan，MD new |
| Early Phase 1 | 43 | |
| Phase 1 | 337 | |
| Phase 1/2 | 269 | |
| Phase 2 | 940 | |
| Phase 2/3 | 34 | |
| Phase 3 | 398 | |
| Phase 4 | 68 |
| NCT ID | Title | Sponsor | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT07436663 | Comparative Study Between (SGLT-2i) and (DPP-4i) in the Prevention of DIC | Tanta University | Recruiting | 2026-10-15 |
| NCT07195344 | Study Aiming to Compare the Plasma Exposure of the Payload (Free-DXd) in Patients Treated… | Institut Claudius Regaud | Recruiting | 2026-10-08 |
| NCT06274515 | A Study to Investigate Mechanisms of Resistance to Breast Cancer Therapies | Hoffmann-La Roche | Recruiting | 2026-10-06 |
| NCT07257484 | Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors | Weill Medical College of Cornell University | Recruiting | 2026-07-22 |
| NCT07252726 | Evaluating Dose Timing (Morning vs Evening) of Endocrine-based Therapies in Metastatic… | Ottawa Hospital Research Institute | Recruiting | 2026-07-17 |
| NCT07600164 | Real-world Study of Pyrotinib-containing Regimens of Advanced HER2-positive Breast Cancer | Peking University People's Hospital | Recruiting | 2026-07-13 |
| NCT07220967 | A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement | Memorial Sloan Kettering Cancer Center | Recruiting | 2026-07-10 |
| NCT07695259 | Olaparib+Trastuzumab+Pertuzumab Neoadjuvant for Elderly HER2+ Breast Cancer | Wen-Ming Cao | Recruiting | 2026-07-10 |
| NCT05753618 | Evaluating Omission of Granulocyte Colony-stimulating Factors in Breast Cancer Patients… | Ottawa Hospital Research Institute | Recruiting | 2026-07-08 |
| NCT06169371 | Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI) | University of Illinois at Chicago | Recruiting | 2026-07-07 |
| NCT05183126 | Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With… | University of Michigan Rogel Cancer Center | Recruiting | 2026-07-02 |
| NCT05376878 | An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+… | City of Hope Medical Center | Recruiting | 2026-07-01 |
| NCT03096418 | Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response | University of Wisconsin, Madison | Recruiting | 2026-06-16 |
| NCT04921137 | Evaluating Harms and Benefits of Endocrine Therapy in Patients ≥70 Years of Age With… | Ottawa Hospital Research Institute | Recruiting | 2026-05-28 |
| NCT07578064 | A Randomized, Self-controlled Post-marketing Clinical Study on the Comparison of Shengbai… | Hongxia Wang | Recruiting | 2026-05-11 |
| NCT07042581 | A Study of Revaree Plus in People With Breast Cancer | Memorial Sloan Kettering Cancer Center | Recruiting | 2026-02-06 |
| NCT04373564 | Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based… | Guerbet | Recruiting | 2026-01-22 |
| NCT07308717 | Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART)… | Memorial Sloan Kettering Cancer Center | Recruiting | 2025-12-30 |
| NCT07257679 | Gentle Touch for Post-Mastectomy Lymphedema | I.R.C.C.S. Fondazione Santa Lucia | Recruiting | 2025-12-02 |
| NCT06934239 | A Trial Comparing Screening Mammography With and Without Assistance From Artificial… | Jonsson Comprehensive Cancer Center | Recruiting | 2025-11-26 |
| NCT06230055 | Intrathecal Chemotherapy Through Ommaya Reservoir Upon Her-2 Negative Breast Cancer With… | Fudan University | Recruiting | 2025-11-25 |
| NCT06072807 | Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer | Weill Medical College of Cornell University | Recruiting | 2025-11-24 |
| NCT07158164 | DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment | Rutgers, The State University of New Jersey | Recruiting | 2025-11-13 |
| NCT06574022 | Post-mastectomy Recovery: Comparing Preoperative PECS-II Blocks With Intraoperative… | University of Cincinnati | Recruiting | 2025-11-04 |
| NCT06491680 | Cardiotoxicity in Breast Cancer Patients | Helwan University | Recruiting | 2025-09-22 |
Fudan University (139) · Memorial Sloan Kettering Cancer Center (104) · M.D. Anderson Cancer Center (97) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (60) · National Cancer Institute (NCI) (57) · AstraZeneca (53) · Mayo Clinic (49) · Dana-Farber Cancer Institute (47) · Cancer Institute and Hospital, Chinese Academy of Medical Sciences (42) · City of Hope Medical Center (42)